Vascular malformations. Part II: Associated syndromes

Journal of the American Academy of Dermatology

Volumn 56, Issue 4, 2007, Pages 541-564

  Garzon, Maria C ^a   Huang, Jennifer T ^b   Enjolras, Odile ^c   Frieden, Ilona J ^d  

^a Howard Hughes Medical Institute   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; OCTREOTIDE; PHOSPHODIESTERASE INHIBITOR; STEROID;

ADAMS OLIVER SYNDROME; ANGIOOSTEOHYPERTROPHY SYNDROME; ARTERIOVENOUS MALFORMATION; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; BANNAYAN RILEY RUVALCABA SYNDROME; BECKWITH WIEDEMANN SYNDROME; BLOOD CLOTTING DISORDER; BOCKENHEIMER SYNDROME; CLINICAL FEATURE; COBB SYNDROME; CONGENITAL BLOOD VESSEL MALFORMATION; CUTIS MARMORATA TELANGIECTATICA CONGENITA; DISEASE ASSOCIATION; ENTEROPATHY; GLAUCOMA; GORHAM STOUT SYNDROME; HEMIHYPERPLASIA MULTIPLE LIPOMATOSIS SYNDROME; HUMAN; MACROCEPHALY; MORBIDITY; MULTIPLE CANCER; NEVUS FLAMMEUS; NOVA SYNDROME; OSTEOCHONDROMA; PATHOGENESIS; PHAKOMATOSIS PIGMENTOVASCULARIS; PRIORITY JOURNAL; PROGNOSIS; PULSED DYE LASER; RADIODIAGNOSIS; RENDU OSLER WEBER DISEASE; REVIEW; ROBERTS SYNDROME; RUBINSTEIN SYNDROME; SEIZURE; SKIN BLOOD VESSEL DISORDER; STURGE WEBER SYNDROME; SYSTEMIC DISEASE; THROMBOCYTOPENIA ABSENT RADIUS SYNDROME; WYBURN MASON SYNDROME;

ARTERIES; ARTERIOVENOUS MALFORMATIONS; CAPILLARIES; FEMALE; HUMANS; INCIDENCE; KLIPPEL-TRENAUNAY-WEBER SYNDROME; MALE; NEUROCUTANEOUS SYNDROMES; PROGNOSIS; RISK ASSESSMENT; STURGE-WEBER SYNDROME; VASCULAR DISEASES; VEINS;

EID: 33947130241     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.05.066     Document Type: Review

References (200)

1. Sturge W.A. A case of partial epilepsy apparently due a lesion of one of the vasomotor centers of the brain. Clin Soc Trans 12 (1879) 162-167
2. In: Mulliken J.B., and Young A.E. (Eds). Vascular birthmarks and hemangiomas: capillary (port-wine) and other telangiectatic stains (1988), WB Saunders, Philadelphia
3. Ambrosetto P., Ambrosetto G., Michelucci R., and Bacci A. Sturge-Weber syndrome without port-wine facial nevus. Report of 2 cases studied by CT. Childs Brain 10 (1983) 387-392
4. In: Demis D.J., Dobson R.L., and Maguire J. (Eds). Clinical dermatology (1995), JB Lippincott & Co, Philadelphia
5. Alexander G.L. Sturge Weber syndrome. In: Vinken P.J., and Bruyn G.W. (Eds). Handbook of clinical neurology. The phakomatoses (1972), North-Holland Publishing, Amsterdam 223-240
6. Enjolras O., Riche M.C., and Merland J.J. Facial port-wine stains and the Sturge-Weber syndrome. Pediatrics 76 (1985) 48-51
7. Tallman B., Tan O.T., Morelli J.G., Piepenbrink J., Stafford T.J., Trainor S., et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics 87 (1991) 323-327
8. Enjolras O., and Mulliken J.B. The current management of vascular birthmarks. Pediatr Dermatol 10 (1993) 311-333
9. Wilson S., Venzel J.M., and Miller R. Angiography, gingival hyperplasia and Sturge-Weber syndrome: report of case. J Dent Child 53 (1986) 283-286
10. Furukawa T., Igata A., and Toyakura Y. Sturge-Weber and Klippel Trenaunay syndrome with nevus of Ota and Ito. Arch Dermatol 102 (1970) 640-645
11. Leung A.K., Lowry R.B., Mitchell I., Martin S., and Cooper D.M. Klippel-Trenaunay and Sturge-Weber syndrome with extensive Mongolian spots, hypoplastic larynx and subglottic stenosis. Clin Exp Dermatol 13 (1988) 128-132
12. Griffiths P.D., Blaser S., Boodram M.B., Armstrong D., and Harwood-Nash D. Choroid plexus size in young children with Sturge-Weber syndrome. Am J Neuroradiol 17 (1996) 175-180
13. Griffiths P.D. Sturge-Weber syndrome revisited: the role of neuroradiology. Neuropediatrics 27 (1996) 284-294
14. Griffiths P.D., Boodram M.B., Blaser S., Armstrong D., Gilday D.L., and Harwood-Nash D. 99mTechnetium HMPAO imaging in children with the Sturge-Weber syndrome: a study of nine cases with CT and MRI correlation. Neuroradiology 39 (1997) 219-224
15. Paller A.S. The Sturge -Weber syndrome. Pediatr Dermatol 4 (1987) 300-304
16. Sujansky E., and Conradi M. Sturge-Weber syndrome: age of onset of seizures and glaucoma and prognosis for affected children. J Child Neurol 10 (1995) 49-58
17. Pascual-Castroviejo I., Diaz-Gonzalez C., Garcia-Melian R.M., Gonzalez-Casado I., and Munoz-Hiraldo E. Sturge-Weber syndrome: study of 40 patients. Pediatr Neurol 9 (1993) 283-288
18. Bebin E.M., and Gomez M.R. Prognosis in Sturge-Weber disease: comparison of unihemispheric and bihemispheric involvement. J Child Neurol 3 (1988) 181-184
19. Sujansky E., and Conradi S. Outcome of Sturge-Weber syndrome in 52 adults. Am J Med Genet 57 (1995) 35-45
20. Thomas-Sohl K.A., Vaslow D.F., and Maria B.L. Sturge-Weber syndrome: a review. Pediatr Neurol 30 (2004) 303-310
21. Peterman A.F., Hayles A.B., Dockerty M.B., and Love J.G. Encephalotrigeminal angiomatosis (Sturge-Weber syndrome). Clinical study of thirty-five cases. JAMA 167 (1958) 2169-2176
22. Cambon H., Truelle J.L., Baron J.C., Chiras J., Tran Dinh S., and Chatel M. Focal chronic ischemia and concomitant migraine: an atypical form of Sturge-Weber angiomatosis?. Rev Neurol (Paris) 143 (1987) 588-594
23. Greenwald M.J., and Weiss A. Ocular manifestations of neurocutaneous syndromes. Pediatr Dermatol 2 (1984) 98-117
24. Cibis G.W., Tripathi R., and Tripathi B.J. Glaucoma in Sturge-Weber syndrome. Ophthalmology 91 (1984) 1061-1071
25. Couly G.F., and Le Douarin N.M. Mapping of the early neural primordium in quail-chick chimeras. II. The prosencephalic neural plate and neural folds: implications for the genesis of cephalic human congenital abnormalities. Dev Biol 120 (1987) 198-214
26. Marti-Bonmati L., Menor F., Poyatos C., and Cortina H. Diagnosis of Sturge-Weber syndrome: comparison of the efficacy of CT and MR imaging in 14 cases. Am J Roentgenol 158 (1992) 867-871
27. Welch K., Naheedy M.H., Abroms I.F., and Strand R.D. Computed tomography of Sturge-Weber syndrome in infants. J Comput Assist Tomogr 4 (1980) 33-36
28. Stimac G.K., Solomon M.A., and Newton T.H. CT and MR of angiomatous malformations of the choroid plexus in patients with Sturge-Weber disease. Am J Neuroradiol 7 (1986) 623-627
29. Chamberlain M.C., Press G.A., and Hesselink J.R. MR imaging and CT in three cases of Sturge-Weber syndrome: prospective comparison. Am J Neuroradiol 10 (1989) 491-496
30. Sperner J., Schmauser I., Bittner R., Henkes H., Bassir C., Sprung C., et al. MR-imaging findings in children with Sturge-Weber syndrome. Neuropediatrics 21 (1990) 146-152
31. Elster A.D., and Chen M.Y. MR imaging of Sturge-Weber syndrome: role of gadopentetate dimeglumine and gradient-echo techniques. AJNR Am J Neuroradiol (1990) 11685-11689
32. Chugani H.T., and Dietrich R.B. Sturge-Weber syndrome. Recent developments in neuroimaging and surgical considerations. In: Fukuyama Y., Suzuki Y., Kamoshita S., and Casear P. (Eds). Fetal and perinatal neurology (1992), Karger, Basel 187-196
33. Adamsbaum C., Pinton F., Rolland Y., Chiron C., Dulac O., and Kalifa G. Accelerated myelination in early Sturge-Weber syndrome: MRI-SPECT correlations. Pediatr Radiol 26 (1996) 759-762
34. Mentzel H.J., Dieckmann A., Fitzek C., Brandl U., Reichenbach J.R., and Kaiser W.A. Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiol 35 (2005) 85-90 Epub 2004 Oct 6
35. Vogl T.J., Stemmler J., Bergman C., Pfluger T., Egger E., and Lissner J. MR and MR angiography of Sturge-Weber syndrome. AJNR Am J Neuroradiol 14 (1993) 417-425
36. Griffiths P.D. Sturge-Weber syndrome revisited: the role of neuroradiology. Neuropediatrics 27 (1996) 284-294
37. Young A.E. Combined vascular malformations. In: Mulliken J.B., and Young A.E. (Eds). Vascular birthmarks and hemangiomas: capillary (port-wine) and other telangiectatic stains (1988), WB Saunders, Philadelphia 246-274
38. Mattassi R. Differential diagnosis in congenital vascular-bone syndromes. Semin Vasc Surg 6 (1993) 233-244
39. Klippel L.M., and Trenaunay P. Du naevus variqueux osté ohypertrophique. Arch Gen Med (Paris) 185 (1900) 641-672
40. Gloviczki P., Hollier L.H., Telander R.L., Kaufman B., Bianco A.J., and Stickler G.B. Surgical implications of Klippel Trenaunay syndrome. Ann Surg 197 (1983) 353-362
41. Telander R.L., Kaufman B.H., Gloviczki P., Stickler G.B., and Hollier L.H. Prognosis and management of lesions of the trunk in children with Klippel-Trenaunay syndrome. J Pediatr Surg 19 (1984) 417-422
42. Maari C., and Frieden I.J. Klippel-Trenaunay syndrome: the importance of "geographic stains" in identifying lymphatic disease and risk of complications. J Am Acad Dermatol 51 (2004) 391-398
43. Servelle M. Klippel and Trenaunay's syndrome. Ann Surg 201 (1985) 365-373
44. Gloviczki P., Stanson A.W., Stickler G.B., Johnson C.M., Toomey B.J., Meland N.B., et al. Klippel Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 110 (1991) 469-479
45. Viljoen D., Saxe N., Pearn J., and Beighton P. The cutaneous manifestations of the Klippel-Trenaunay-Weber syndrome. Clin Exp Dermatol 12 (1987) 12-17
46. Baskerville P.A., Ackroyd J.S., Lea Thomas M., and Browse N.L. The Klippel-Trenaunay syndrome: clinical radiological and haemodynamic features and management. Br J Surg 72 (1985) 232-236
47. Bird L.M., Jones M.C., Kuppermann N., and Huskins W.C. Gram-negative bacteremia in four patients with Klippel-Trenaunay-Weber syndrome. Pediatrics 97 (1996) 739-741
48. Neubert A.G., Golden M.A., and Rose N.C. Kasabach-Merritt coagulopathy complicating Klippel-Trenaunay-Weber syndrome in pregnancy. Obstet Gynecol 85 (1995) 831-833
49. Vissers W., Van Steensel M., Steijlen P., Renier W., Van De Kerkhof P., and Van Der Vleuten C. Klippel-Trenaunay syndrome and Sturge-Weber syndrome: variations on a theme?. Eur J Dermatol 13 (2003) 238-241
50. Baskerville P.A., Ackroyd J.S., and Browse N.L. The etiology of Klippel Trenaunay syndrome. Ann Surg 202 (1985) 624-627
51. Aelvoet G.E., Jorens P.G., and Roelen L.M. Genetic aspects of the Klippel-Trenaunay syndrome. Br J Dermatol 126 (1992) 603-607
52. Happle R. Klippel-Trenaunay syndrome: is it a paradominant trait?. Br J Dermatol 128 (1992) 465
53. Whelan A.J., Watson M.S., and Porter F.D. Klippel-Trenaunay syndrome associated with a 5:11 balanced translocation. Am J Med Genet 59 (1995) 492-494
54. Tian X.L., Kadaba R., You S.A., Liu M., Timur A.A., Yang L., et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427 (2004) 640-645
55. Timur A.A., Sadgephour A., Graf M., Schwartz S., Libby E.D., Driscoll D.J., et al. Identification and molecular characterization of a de novo supernumerary ring chromosome 18 in a patient with Klippel-Trenaunay syndrome. Ann Hum Genet 68 (2004) 353-361
56. Kanterman R.Y., Witt P.D., Hsieh P.S., and Picus D. Klippel-Trenaunay syndrome: findings and percutaneous intervention. AJR Am J Roentgenol 167 (1996) 989-995
57. Greene A.K., Kieran M., Burrows P.E., Mulliken J.B., Kasser J., and Fishman S.J. Wilms tumor screening is unnecessary in Klippel-Trenaunay syndrome. Pediatrics 113 (2004) e326-e329
58. Van Lohuizen C.H.J. Uber eine seltene ange borne Hautanomalie (Cutis marmorata telangiectatica congenita). Acta Derm Venereol (Stockh) 3 (1922) 202-211
59. Picascia D.D., and Esterly N.B. Cutis marmorata telangiectatica congenita: report of 22 cases. J Am Acad Dermatol 20 (1989) 1098-1104
60. South D.A., and Jacobs A.H. Cutis marmorata telangiectatica congenita (congenital generalized phlebectasia). Pediatrics 93 (1978) 944-949
61. Way B.H., Herrmann J., Gilbert E.F., Johnson S.A., and Opitz J.M. Cutis marmorata telangiectatica congenita. J Cutan Pathol 1 (1974) 10-25
62. Devillers A.C.A., de Waard-van der Spek F.B., and Oranje A.P. Cutis marmorata telangiectatica congenita. Clinical features in 35 cases. Arch Dermatol 135 (1999) 34-38
63. Petrozzi J.W., Rahn E.K., Mofenson H., and Greensher J. Cutis marmorata telangiectatica congenita. Arch Dermatol 101 (1970) 74-77
64. Del Giudice S.M., and Nydorf E.D. Cutis marmorata telangiectatica congenita with multiple congenital anomalies. Arch Dermatol 122 (1986) 1060-1061
65. Powell S.T., and Su W.P. Cutis marmorata telangiectatica congenita: report of nine cases and review of the literature. Cutis 34 (1984) 305-312
66. Pehr K., and Moroz B. Cutis marmorata telangiectatica congenita: long-term follow-up, review of the literature, and report of a case in conjunction with congenital hypothyroidism. Pediatr Dermatol 10 (1993) 6-11
67. Weilepp A.E., and Eichenfield L.F. Association of glaucoma with cutis marmorata telangiectatica congenita: a localized anatomic malformation. J Am Acad Dermatol 35 (1996) 276-278
68. Robertson S.P., Gattas M., Rogers M., and Ades L.C. Macrocephaly-cutis marmorata telangiectatica congenita: report of five patients and a review of the literature. Clin Dysmorphol 9 (2000) 1-9
69. Lapunzina P., Gairi A., Delicado A., Mori M.A., Torres M.L., Goma A., et al. Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review. Am J Med Genet A 130 (2004) 45-51
70. Rogers M., and Poyzer K.G. Cutis marmorata telangiectatica congenita. Arch Dermatol 118 (1982) 895-899
71. Kennedy C., Oranje A.P., Keizer K., van den Heuvel M.M., and Catsman-Berrevoets C.E. Cutis marmorata telangiectatica congenita. Int J Dermatol 31 (1992) 249-252
72. Kurczynski T.W. Hereditary cutis marmorata telangiectatica congenita. Pediatrics 70 (1982) 52-53
73. Danarti R., Happle R., and Konig A. Paradominant inheritance may explain familial occurrence of cutis marmorata telangiectatica congenita. Dermatology 203 (2001) 208-211
74. Amitai D.B., Fichman S., Merlob P., Morad Y., Lapidoth M., and Metzker A. Cutis marmorata telangiectatica congenita: clinical findings in 85 patients. Pediatr Dermatol 17 (2000) 100-104
75. Adams F.H., and Oliver C.P. Hereditary deformities in man due to arrested development. J Hered 36 (1945) 3-7
76. Scribanu N., and Temtamy S.A. Syndrome of aplasia cutis congenita with terminal transverse defects of the limbs. J Pediatr 87 (1975) 79-82
77. Zapata H.H., Sletten L.J., and Pierpont M.E.M. Congenital cardiac malformations in Adams-Oliver syndrome. Clin Genet 47 (1995) 80-84
78. Toriello H.V., Graff R.G., Florentine M.F., Lacina S., and Moore W.D. Scalp and limb defects with cutis marmorata telangiectatica congenita: Adams-Oliver syndrome?. Am J Med Genet 29 (1988) 269-276
79. Swartz E.N., Santani S., Sandor G.G.S., and Schreiber R.A. Vascular abnormalities in Adams-Oliver syndrome: cause or effect?. Am J Med Genet 82 (1999) 49-52
80. Klinger G., and Merlob P. Adams-Oliver syndrome: autosomal recessive inheritance and new phenotypic-anthropometric findings. Am J Med Genet 79 (1998) 197-199
81. Unay B., Sarici S.U., Gul D., Akin R., and Gokcay E. Adams-Oliver syndrome: further evidence for autosomal recessive inheritance. Clin Dysmorphol 10 (2001) 223-225
82. Verdyck P., Holder-Espinasse M., Hul W.V., and Wuyts W. Clinical and molecular analysis of nine families with Adams-Oliver syndrome. Eur J Hum Genet 11 (2003) 457-463
83. Harrison M.S. The Treacher Collins-Franceschetti syndrome. J Laryngol Otol 71 (1957) 597-603
84. Hall B.D., deLorimier A., and Foster L.H. A new syndrome of hemangiomatous branchial clefts, lip pseudoclefts, and unusual facial appearance. Am J Med Genet 14 (1983) 135-138
85. DaSilva E.O., and Bezerra L.H. The Roberts syndrome. Hum Genet 61 (1982) 372-374
86. Zergollern L., and Hitrec V. Four siblings with Roberts syndrome. Clin Genet 21 (1982) 1-6
87. Urban M., Rogalla P., Tinschert S., and Krietsch P. Tetraphocomelia and bilateral cleft lip in a historical case of Roberts syndrome. Am J Med Genet 72 (1997) 307-314
88. Tomkins D., Hunter A., and Roberts M. Cytogenetic findings in Roberts-SC phocomelia syndrome(s). Am J Med Genet 4 (1979) 17-26
89. Sinha A.K., Verma R.S., and Mani V.J. Clinical heterogeneity of skeletal dysplasia in Roberts syndrome: a review. Hum Hered 44 (1994) 121-126
90. Rubinstein J.H., and Taybi H. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 105 (1963) 88-108
91. Hennekam R.C.M., Van Den Boogaard M.J., Sibbles B.J., and Van Spijker H.G. Rubinstein-Taybi syndrome in The Netherlands. Am J Med Genet Suppl 6 (1990) 17-29
92. Wallerstein R., Anderson C.E., Hay B., Gupta P., Gibas L., Ansari K., et al. Submicroscopic deletions at 16p13.3 in Rubinstein-Taybi syndrome: frequency and clinical manifestations in a North American population. J Med Genet 34 (1997) 203-206
93. Petrij F., Giles R.H., Dauwerse H.G., Saris J.J., Hennekam R.C., Masuno M., et al. Rubinstein-Taybi syndrome cause by mutations in the transcriptional co-activator CBP. Nature 376 (1995) 348-351
94. Alarcon J.M., Malleret G., Touzani K., Vronskaya S., Ishii S., Kandel E.R., et al. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42 (2004) 947-959
95. Bourtchouladze R., Lidge R., Catapano R., Stanley J., Gossweiler S., Romashko D., et al. A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci U S A 100 (2003) 10518-10522
96. Hall J.G., Levin J., Kuhn J.P., Ottenheimer E.J., van Berkum K.A., and McKusick V.A. Thrombocytopenia with absent radius (TAR). Medicine 48 (1969) 411-439
97. Anayane-Yeboa K., Jaramillo S., Nagel C., and Grebin B. Tetraphocomelia in the syndrome of thrombocytopenia with absent radii (TAR syndrome). Am J Med Genet 20 (1985) 571-576
98. Ashinoff R., and Geronemus R.G. Thrombocytopenia-absent radii syndrome and lack of response to the pulsed dye laser. [letter]. Arch Dermatol 126 (1990) 1520-1521
99. Ballmaier M., Schulze H., Cremer M., Folman C.C., Strauss G., and Weite K. Defective c-Mpl signaling in the syndrome of thrombocytopenia with absent radii. Stem Cells 16 (1998) Suppl 2:177-84
100. Wu N.F., and Kushnick T. The Beckwith-Wiedemann syndrome. The exophalos-macroglossia-gigantism syndrome. Clin Pediatr 13 (1974) 452-457
101. Niemitz E.L., DeBaun M.R., Fallon J., Murakami K., Kugoh H., Oshimura M., et al. Microdeletion of LIT1 in familial Beckwith-Wiedemann syndrome. Am J Hum Genet 75 (2004) 844-849
102. Weksberg R., Smith A.C., Squire J., and Sadowski P. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet (2003) 12Spec No 1:R61-8
103. Nova H.R. Familial communicating hydrocephalus, posterior cerebellar agenesis, mega cisterna magna and port-wine nevi. Report on five members of one family. J Neurosurg 51 (1979) 862-865
104. Torrelo A., Zambrano A., and Happle R. Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis. Br J Dermatol 148 (2003) 342-345
105. Hasegawa Y., and Yashura M. Phakomatosis pigmentovascularis type IV a. Arch Dermatol 121 (1985) 651-655
106. Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol 141 (2005) 385-388
107. Sawada Y., Iwata M., and Mitsuhashi Y. Nevus pigmentovascularis. Ann Plast Surg 25 (1990) 142-145
108. Ruiz-Maldonado R., Tamayo L., Laterza A.M., Brawn G., and Lopez A. Phacomatosis pigmentovascularis: a new syndrome? Report of four cases. Pediatr Dermatol 4 (1987) 189-196
109. Libow L. Phakomatosis pigmentovascularis type IIIb. J Am Acad Dermatol 29 (1993) 305-307
110. Guiglia M.C., and Prendiville J.S. Multiple granular cell tumors associated with giant speckled lentiginous nevus and nevus flammeus in a child. J Am Acad Dermatol 24 (1991) 359-363
111. Gilliam A.C., Ragge N.K., Perez M.I., and Bolognia J.L. Phakomatosis pigmentovascularis IIb with iris mammillations. Arch Dermatol 129 (1993) 340-342
112. Luna M.L., Barquin M.A., Casas J.G., and Sidelsky S. Phacomatosis pigmentovascularis with selective IgA deficiency. Pediatr Dermatol 12 (1995) 159-163
113. Suzuki K., Ishizaki H., and Takahashi H. [Phacomatosis pigmentovascularis IIIb associated with porokeratosis, acanthosis nigricans and endocrinopathy in brother and sister.]. Skin Res (Hifu) 32 (1990) 65-70 Japanese, with an English summary
114. Danarti R., and Happle R. Paradominant inheritance of twin spotting: phacomatosis pigmentovascularis as a further possible example. Eur J Dermatol 13 (2003) 612
115. Happle R. Allelic somatic mutations may explain vascular twin nevi. Hum Genet 86 (1991) 321-322
116. Happle R. Mosaicism in human skin. Arch Dermatol 129 (1993) 1460-1470
117. Teekhasaenee C., and Ritch R. Glaucoma in phakomatosis pigmentovascularis. Ophthalmology 104 (1997) 150-157
118. Bonnet P., Dechaume J., and Blanc E. L'aneurysme cirsoide de la retine (aneurysme vasemeaux). J Med Lyon 18 (1937) 165-178
119. Wyburn-Mason R. Arteriovenous aneurysm of midbrain and retina, facial naevi and mental changes. Brain 66 (1943) 163-203
120. Theron J., Newton T.H., and Hoyt W.F. Unilateral retinocephalic vascular malformations. Neuroradiology 7 (1974) 185-196
121. Patel U., and Gupta S.C. Wyburn-Mason syndrome. A case report and review of the literature. Neuroradiology 31 (1990) 544-546
122. Willinsky R.A., Lasjaunias P., Terbrugge K., and Burrows P. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology 32 (1990) 207-210
123. Lin A.E., Gorlin R.J., Lurie I.W., Brunner H.G., van der Burgt I., Naumchik I.V., et al. Further delineation of the branchio-oculo-facial syndrome. Am J Med Genet 56 (1995) 42-59
124. Gabriel K.R., Crawford A.H., Roy D.R., True M.S., and Sauntry S. Percutaneous epiphyseodesis. J Pediatr Orthop 14 (1994) 358-362
125. Eerola I., Boon L.M., Mulliken J.B., Burrows P.E., Dompmartin A., Watanabe S., et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73 (2003) 1240-1249
126. Boon L.M., Mulliken J.B., and Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 15 (2005) 265-269
127. Bean W.B. Blue rubber bleb nevi of the skin and gastrointestinal tract. Vascular spiders and related lesions of the skin (1958), Charles Thomas, Springfield (IL) 178-185
128. Oranje A.P. Blue rubber bleb nevus syndrome. Pediatr Dermatol 3 (1986) 304-310
129. Morris S.J., Kaplan S.R., Ballan K., and Tedesco F.J. Blue rubber-bleb nevus syndrome. JAMA 239 (1978) 1887
130. McCarthy J.C., Goldberg M.J., and Zimbler S. Orthopaedic dysfunction in the blue rubber-bleb nevus syndrome. J Bone Joint Surg [Am] 64 (1982) 280-283
131. Wong Y.C., Li Y.W., and Chang M.H. Gastrointestinal bleeding and paraparesis in blue rubber bleb nevus syndrome. Pediatr Radiol 24 (1994) 600-601
132. Hofhuis W.J., Oranje A.P., Bouquet J., and Sinaasappel M. Blue rubber bleb nevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis. Eur J Pediatr 149 (1990) 526-528
133. Waybright E.A., Selhorst J.B., Rosenblum W.I., and Suter C.G. Blue rubber bleb nevus syndrome with CNS involvement and thrombosis of a vein of Galen malformation. Ann Neurol 3 (1978) 464-467
134. Moodley M., and Ramdial P. Blue rubber bleb nevus syndrome: case report and review of the literature. Pediatrics 92 (1993) 160-162
135. McCannel C.A., Hoenig J., Umlas J., Woog J.J., Newman A.N., and Bateman J.B. Orbital lesions in the blue rubber bleb nevus syndrome. Ophthalmology 103 (1996) 933-936
136. Radke M., Waldschmidt J., Stolpe H.J., Mix M., and Richter I. Blue rubber-bleb-nevus syndrome with predominant urinary bladder hemangiomatosis. Eur J Pediatr Surg 3 (1993) 313-316
137. Busund B., Stray-Pedersen S., Iversen O., and Austad J. Blue rubber bleb nevus syndrome with manifestations in the vulva. Acta Obstet Gynecol Scand 72 (1993) 310-313
138. Jorizzo J.R., and Amparo E.G. MR imaging of blue rubber bleb nevus syndrome. J Comput Assist Tomogr 10 (1986) 686-688
139. Olsen T.G., Milroy S.K., Goldman L., and Fidler J.P. Laser surgery for blue rubber bleb nevus. Arch Dermatol 155 (1979) 81-82
140. Buchi K.N. Vascular malformations of the gastrointestinal tract. Surg Clin North Am 72 (1992) 559-570
141. Morris L., Lynch P.M., Gleason Jr. W.A., Schauder C., Pinkel D., and Duvic M. Blue rubber bleb nevus syndrome: laser photocoagulation of colonic hemangiomas in a child with microcytic anemia. Pediatr Dermatol 9 (1992) 91-94
142. Boente M.D., Cordisco M.R., Frontini M.D., and Asial R.A. Blue rubber bleb nevus (Bean syndrome): evolution of four cases and clinical response to pharmacologic agents. Pediatr Dermatol 16 (1999) 222-227
143. Apak H., Celkan T., Ozkan A., Yildiz I., Aydemir E.H., Ozdil S., et al. Blue rubber bleb nevus syndrome associated with consumption coagulopathy: treatment with interferon. Dermatology 208 (2004) 345-348
144. Gonzalez D., Elizondo B.J., Haslag S., Buchanan G., Burdick J.S., Guzzetta P.C., et al. Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome. J Pediatr Gastroenterol Nutr 33 (2001) 183-188
145. Weidemann HR, Burgio GR Aidenhoff P. The Proteus syndrome. Eur J Pediatr 1983;140:5-12.
146. Delaporte E., Wendehenne R., Descamps S., Bitbol-Duneton V., Hatron P.Y., Piette F., et al. Dysplasias hamartomateux avec hemihypertrophie: deux observations dont il syndrome Protee. Arch Pediatr 2 (1995) 52-56
147. Havard S., Enjolras O., Lessana-Leibowitch M., and Escande J.P. Protee: huit cas. Ann Dermatol Venereol 121 (1994) 303-308
148. Biesecker L.G., Happle R., Mulliken J.B., Weksberg R., Graham Jr. J.M., Viljoen D.L., et al. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet 84 (1999) 389-395
149. Turner J.T., Cohen Jr. M.M., and Biesecker L.G. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. Am J Med Genet A 130 (2004) 111-122
150. Viljoen D.L., Saxe N., and Temple-Camp C. Cutaneous manifestations of Proteus syndrome. Pediatr Dermatol 5 (1988) 14-21
151. Cohen Jr. M.M. Proteus syndrome: clinical evidence for somatic mosaicism and selective review. Am J Med Genet 47 (1993) 645-652
152. Samlaska C.P., Levin S.W., James W.D., Benson P.M., Walker J.C., and Perlik P.C. Proteus syndrome. Arch Dermatol 125 (1989) 1109-1114
153. Nazzaro V., Cambiaghi S., Montagnani A., Brusasco A., Cerri A., and Caputo R. Proteus syndrome. Ultrastructural study of linear verrucous and depigmented nevi. J Am Acad Dermatol 25 (1991) 377-383
154. Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 16 (1987) 899-906
155. Cohen Jr. M.M., Turner J.T., and Biesecker L.G. Proteus syndrome: misdiagnosis with PTEN mutations. Am J Med Genet A 122 (2003) 323-324
156. Lacombe D., Taieb A., Vergnes P., Sarlangue J., Chateil J.F., Bucco P., et al. Proteus syndrome in seven patients. Genet Couns 2 (1990) 93-101
157. Zhou X., Hampel H., Thiele H., Gorlin R.J., Hennekam R.C., Parisi M., et al. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 358 (2001) 210-211
158. Nguyen D., Turner J.T., Olsen C., Biesecker L.G., and Darling T.N. Cutaneous manifestations of proteus syndrome: correlations with general clinical severity. Arch Dermatol 140 (2004) 947-953
159. Biesecker L.G., Peters K.F., Darling T.N., Choyke P., Hill S., Schimke N., et al. Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia. Am J Med Genet 79 (1998) 311-318
160. Cohen M.M. Bannayan-Riley-Ruvalcaba syndrome: renaming three formerly recognized syndromes as one etiologic entity. Am J Med Genet 35 (1990) 291
161. Gorlin R.J., Cohen Jr. M.M., Condon L.M., and Burke B.A. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 44 (1992) 307-314
162. Fargnoli M.C., Orlow S.J., Semel-Concepcion J., and Bolognia J.L. Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome. Arch Dermatol 132 (1996) 1214-1218
163. Arch E.M., Goodman B.K., Van Wesep R.A., Liaw D., Clarke K., Parsons R., et al. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 71 (1997) 489-493
164. Zori R.T., Marsh D.J., Graham G.E., Marliss E.B., and Eng C. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 80 (1998) 399-402
165. Marsh D.J., Kum J.B., Lunetta K.L., Bennett M.J., Gorlin R.J., Ahmed S.F., et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8 (1999) 1461-1472
166. Blum R.R., Rahimizadeh A., Kardon N., Lebwohl M., and Wei H. Genital lentigines in a 6-year-old boy with a family history of Cowden's disease: clinical and genetic evidence of the linkage between Bannayan-Riley-Ruvacalba syndrome and Cowden's disease. J Cutan Med Surg 5 (2001) 228-230
167. Hendriks Y.M., Verhallen J.T., van der Smagt J.J., Kant S.G., Hilhorst Y., Hoefsloot L., et al. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases. Fam Cancer 2 (2003) 79-85
168. McDermott A.L., Dutt S.N., Chavda S.V., and Morgan D.W. Maffucci's syndrome: clinical and radiological features of a rare condition. J Laryngol Otol 115 (2001) 845-847
169. Lee N.H., Choi E.H., Choi W.K., Lee S.H., and Ahn S.K. Maffucci's syndrome with oral and intestinal haemangioma. Br J Dermatol 140 (1999) 968-969
170. Auyeung J., Mohanty K., and Tayton K. Maffucci lymphangioma syndrome: an unusual variant of Ollier's disease, a report and a review of the literature. J Pediatr Orthop B 12 (2003) 147-150
171. Yanez S., Val-Bernal J.F., Mira C., Echevarria M.A., Gonzalez-Vela M.C., and Arce F. Spindle cell hemangioendotheliomas associated with multiple skeletal enchondromas: a variant of Maffucci's syndrome. Gen Diagn Pathol 143 (1998) 331-335
172. Hisaoka M., Aoki T., Kouho H., Chosa H., and Hashimoto H. Maffucci's syndrome associated with spindle cell hemangioendotheliomas. Skeletal Radiol 26 (1997) 191-194
173. Hopyan S., Gokgoz N., Poon R., Gensure R.C., Yu C., Cole W.G., et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 30 (2002) 306-310
174. Roseman L.B., Sangiorgi L., Bruijn I.H., Mainil-Varlet P., Bertoni F., Cleton-Jansen A.M., et al. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1mutation p.R150C. Hum Mutat 24 (2004) 466-473
175. Gorham L.W., and Stout A.P. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37 (1955) 985-1004
176. Bruch-Gerharz D., Gerharz C.D., Stege H., Krutmann J., Pohl M., Koester R., et al. Cutaneous vascular malformations in disappearing bone (Gorham-Stout) disease. JAMA 289 (2003) 1479-1480
177. Dickson G.R., Mollan R.A., and Carr K.E. Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease. Histochemistry 87 (1987) 569-572
178. Hirayama T., Sabokbar A., Itonaga I., Watt-Smith S., and Athanasou N.A. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 195 (2001) 624-630
179. van Geest A.J., Veraart J.C., de Haan M., and Neumann H.A. Bockenheimer's syndrome. J Eur Acad Dermatol Venereol 12 (1999) 165-168
180. Eerola I., Plate K.H., Spiegel R., Boon L.M., Mulliken J.B., and Vikkula M. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 9 (2000) 1351-1355
181. Porteous M.E., Burn J., and Proctor S.J. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 29 (1992) 527-530
182. Folz B.J., Lippert B.M., Wollstein A.C., Tennie J., Happle R., and Werner J.A. Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia-analysis of distribution and symptoms. Eur J Dermatol 14 (2004) 407-411
183. Porteous M.E., Burn J., and Proctor S.J. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 29 (1992) 527-530
184. Guttmacher A.E., Marchuk D.A., and White Jr. R.I. Hereditary hemorrhagic telangiectasia. N Engl J Med 333 (1995) 918-924
185. McAllister K.A., Grogg K.M., Johnson D.W., Gallione C.J., Baldwin M.A., Jackson C.E., et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8 (1994) 345-351
186. Berg J.N., Gallione C.J., Stenzel T.T., Johnson D.W., Allen W.P., Schwartz C.E., et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61 (1997) 60-67
187. Johnson D.W., Berg J.N., Baldwin M.A., Gallione C.J., Marondel I., Yoon S.J., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13 (1996) 189-195
188. Fuchizaki U., Miyamori H., Kitagawa S., Kaneko S., and Kobayashi K. Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Lancet 362 (2003) 1490-1494
189. Li D.Y., Sorensen L.K., Brooke B.S., Urness L.D., Davis E.C., Taylor D.G., et al. Defective angiogenesis in mice lacking endoglin. Science 284 (1999) 1534-1537
190. Urness L.D., Sorensen L.K., and Li D.Y. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26 (2000) 328-331
191. Sorensen L.K., Brooke B.S., Li D.Y., and Urness L.D. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol 261 (2003) 235-250
192. Piantanida M., Buscarini E., Dellavecchia C., Minelli A., Rossi A., Buscarini L., et al. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 33 (1996) 441-443
193. Bourdeau A., Dumont D.J., and Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104 (1999) 1343-1351
194. Shovlin C.L., Guttmacher A.E., Buscarini E., Faughnan M.E., Hyland R.H., Westermann C.J., et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 (2000) 66-67
195. Gatti R.A. Ataxia telangiectasia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The molecular and metabolic basis of inherited disease (1996), McGraw-Hill, New York
196. Swift M., Morrell D., Massey R.B., and Chase C.L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325 (1991) 1831-1836
197. Swift M., Reitnauer P.J., Morrell D., and Chase C.L. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316 (1987) 1289-1294
198. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 (1995) 1749-1753
199. Lee Y., Chong M.J., and McKinnon P.J. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J Neurosci 21 (2001) 6687-6693
200. Qi L., Strong M.A., Karim B.O., Armanios M., Huso D.L., and Greider C.W. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res 63 (2003) 8188-8196